Discover

DVA
DaVita Inc.
199.74
300 x 198.43
300 x 199.89
bid
ask
+
7.16
3.72%
300 @ 04:27 PM
199.00 -0.74 (0.37%)
Ytd 75.81%
1y 39.09%
191.57
day range
199.90
101.00
52 week range
202.69
Open 193.67 Prev Close 192.58 Low 191.57 High 199.90 Mkt Cap 12.82B
Vol 498.87K Avg Vol 867.71K EPS 10.38 P/E 19.24 Forward P/E 11.20
Beta 0.84 Short Ratio 9.59 Inst. Own 54.48% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 08-05 50-d Avg 157.63 200-d Avg 134.82 1yr Est 193.71
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.41 2.87 0.46 19.09%
2026-02-02 2025-12 3.24 3.4 0.16 4.94%
2025-10-29 2025-09 3.29 2.51 -0.78 -23.71%
2025-08-05 2025-06 2.7 2.95 0.25 9.26%
2025-05-12 2025-03 1.75 2 0.25 14.29%
2025-02-13 2024-12 2.21 2.24 0.03 1.36%
Upgrade / Downgrade
Date Firm Action From To
2026-05-11 TD Cowen Upgrade Hold Hold
2026-05-08 Truist Securities Upgrade Hold Hold
2026-05-08 Barclays Upgrade Equal-Weight Equal-Weight
2026-05-07 UBS Upgrade Buy Buy
2026-05-06 Deutsche Bank Upgrade Hold Buy
2026-02-04 UBS Upgrade Buy Buy
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Holder
Date Name Relation Quantity Description
2026-05-06 ACKERMAN JOEL Chief Financial Officer 132.43K Sale
2026-03-12 ARWAY PAMELA M. Director 26.70K Stock Award(Grant)
2025-05-14 BERG CHARLES G Director 27.03K Stock Award(Grant)
2026-04-30 BERKSHIRE HATHAWAY, INC. Beneficial Owner of more than 10% of a Class of Security 0.00 Sale
2026-03-12 BERRY CHRISTOPHER MICHAEL Officer 19.64K Stock Award(Grant)
2026-05-05 HEARTY JAMES O Officer 35.95K Sale
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Berkshire Hathaway, Inc 31.76M 6.34B 49.47%
2026-03-30 Blackrock Inc. 2.77M 552.71M 4.31%
2026-03-30 Vanguard Capital Management LLC 2.18M 435.54M 3.40%
2025-12-30 Morgan Stanley 1.48M 295.07M 2.30%
2026-03-30 Vanguard Portfolio Management LLC 1.48M 295.58M 2.30%
2026-03-30 Invesco Ltd. 1.47M 293.24M 2.29%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.12M 223.80M 1.75%
2026-04-29 Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF 1.09M 217.78M 1.70%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 888.25K 177.45M 1.38%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 800.71K 159.96M 1.25%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund 516.49K 103.18M 0.80%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 428.74K 85.65M 0.67%
Split
Split Date
2 : 1 2013-09-09
1.5 : 1 2004-06-16
5 : 3 1997-10-21